Fiche publication


Date publication

avril 2025

Journal

Fundamental & clinical pharmacology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr JOUZEAU Jean-Yves


Tous les auteurs :
Aouichi LL, Pape E, Jouzeau JY, Gibaja V, Aubin-Beale E, Kolodziej A, Feliu C, Marchand E, Gambier N, Scala-Bertola J

Résumé

Ketamine is a psychoactive substance used for its stimulant and hallucinogenic properties. As the use of ketamine may lead to impaired driving, we aimed to assess the occurrence of ketamine in the driving population tested positive for narcotics in roadside checks using oral fluid analysis. Oral fluid concentrations of ketamine and norketamine were examined to determine the percentage of drivers susceptible to ketamine impairment.

Mots clés

addiction, drug abuse, drug testing, ketamine, oral fluid

Référence

Fundam Clin Pharmacol. 2025 04;39(2):e13060